Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Texas Biotechnology reports phase III results with Novastan in HIT and HITTS

May 23, 1997

Molecumetics and Asahi enter anticoagulant collaboration

May 22, 1997

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Searle describes antiplatelet agents

May 20, 1997

3-D describes potent and selective thrombin inhibitors

May 15, 1997

Factor Xa inhibitors from 3-D

May 15, 1997

Fibrinogen antagonists reported by Lilly/Cor Therapeutics

May 14, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Serine protease inhibitors described by 3-D

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...